ArticleInternational journal of behavioral medicine2026
Feasibility of AI-Enabled Chatbots for Pre-consultation in HIV Care in Northern Nigeria.
Article in International journal of behavioral medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDigital health tools are increasingly being used to support HIV care by expanding access to confidential, on-demand information. Despite growing interest, evidence on artificial intelligence (AI)-enabled chatbot use within routine HIV treatment programs in Africa remains limited. We assessed the prevalence, patterns, and determinants of AI chatbot use among people living with HIV (PLHIV) in Kano, northern Nigeria.
methodWe conducted a cross-sectional study among 427 adults on antiretroviral treatment (ART) attending the HIV clinic in a large tertiary referral center in Kano, Nigeria. Using systematic sampling, participants were interviewed using a validated, culturally adapted interviewer-administered questionnaire. The Socio-Ecological Model and the Technology Acceptance Model guided the analyses, while multivariable logistic regression was used to identify independent predictors of HIV-related chatbot use.
resultsMost respondents (75.2%) were aware of AI chatbots. A similar proportion (72.6%) reported ever using one. Approximately 66.5% of participants used chatbots for HIV-related queries, most commonly to obtain general HIV/ART information (36.3%), check ART side effects (23.4%), or prepare questions for clinicians (15.0%). Independent predictors of HIV-related chatbot use included younger age (< 20 vs. ≥ 50 years: adjusted odds ratio (aOR) = 3.35; 95% confidence interval (CI), 1.12-5.21), post-secondary education (vs. none: aOR = 3.23; 95% CI, 1.58-6.25), being married (vs. divorced/widowed: aOR = 2.26; 95% CI, 1.11-6.91), shorter ART duration (< 1 year vs. > 6 years: aOR = 1.91; 95% CI, 1.15-5.67), presence of comorbidities (aOR = 2.61; 95% CI, 1.69-7.69), smartphone ownership (aOR = 2.13; 95% CI, 1.08-7.60), internet access (aOR = 6.67; 95% CI, 3.33-12.50), and English proficiency (aOR = 2.11; 95% CI, 1.13-5.45).
conclusionAI-enabled chatbot use for HIV-related information is common among PLHIV receiving ART in northern Nigeria. Our findings support the need for clinician-endorsed, multilingual, and low-bandwidth chatbot designs, alongside safeguards to reduce misinformation and ensure equitable integration of AI-enabled information tools in HIV treatment programs in Africa.
Indexed as
Identifiers
42736503What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.